DEEPVESSEL Plaque
Overview
DEEPVESSEL Plaque by Keya Medical Technology Co., Ltd. is an AI-powered medical tool designed for the analysis of coronary computed tomography angiography (CCTA) studies.
- What it does:The tool characterizes and quantifies coronary atherosclerotic plaque and stenosis from previously acquired CCTA images. It provides quantitative measurements including total plaque volume, calcified and non-calcified plaque volume, low-density plaque volume, plaque burden, and stenosis severity, along with CAD-RADS stenosis categorization.
- Who it is for:DEEPVESSEL Plaque is intended for qualified clinicians to assess the presence and extent of coronary artery disease (CAD) in adults with suspected or known CAD. This includes specialties such as cardiology and radiology, and it can be utilized in care settings where CCTA studies are performed and interpreted.
- How it fits a clinical or practice workflow:The workflow involves secure transfer of previously acquired CCTA DICOM data. Deep-learning-based segmentation is then performed and reviewed by trained analysts. Finally, quantitative and visual clinical reports are delivered for review by the clinician.
- Notable capabilities:DEEPVESSEL Plaque offers detailed vessel- and patient-level plaque volumes, burden, composition, and stenosis assessment through visual clinical reports.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- AI-powered coronary plaque analysis
- Quantifies plaque burden
- Characterizes plaque composition (calcified, non-calcified, low-density)
- Assesses coronary stenosis
- Provides quantitative plaque measurements
- Generates visual clinical reports
- Segments coronary arteries, vessel walls, and lumen structures
- Supports clinical decision-making for coronary artery disease (CAD)
- Compatible with previously acquired CCTA studies
- Integration with DEEPVESSEL FFR for comprehensive cardiac analysis
Use Cases
- Assessing the presence and extent of coronary atherosclerosis
- Evaluating coronary artery disease (CAD) in adults with suspected or known CAD
- Supporting clinical decision-making for patient management strategies
- Complementing expert CCTA interpretation with standardized, scalable AI-assisted plaque assessment
What Physicians Need to Know
DEEPVESSEL Plaque offers a comprehensive anatomical assessment of coronary artery disease. Combining its quantitative plaque analysis and stenosis evaluation with DEEPVESSEL FFR (a separate, complementary tool for functional assessment) can provide a more complete picture from a single CCTA examination, aiding in more precise risk stratification and personalized treatment planning. The detailed reports, including plaque volumes, burden, composition, and stenosis assessment, can be valuable for monitoring disease progression and guiding therapeutic interventions.
DEEPVESSEL Plaque processes previously acquired CCTA DICOM data through a secure remote workflow. It is designed to complement DEEPVESSEL FFR, with both being separately FDA-cleared products that can be used together for a more comprehensive CCTA assessment.
Details
| Category | Cardiology AI, Radiology & Imaging AI |
| Pricing | Unknown |
| Deployment | Cloud-based |
| Compliance | |
| BAA Available | Unknown |
| HIPAA Compliant | Unknown |
| FDA Status | Cleared AI-estimated |
| Integrations | |
| EHR | Not specified |
| Specialties | Cardiology, Cardiothoracic Surgery, Radiology |
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate DEEPVESSEL Plaque
Videos
Product demos, reviews, and walkthroughs for DEEPVESSEL Plaque.
Company Spotlight: Keya Medical DEEPVESSEL Plaque - Automated Coronary Plaque Phenotyping
mike rawson





